United States Diagnostic and Measurement Devices Market Outlook to 2025

All the vital news, analysis, and commentary curated by our industry experts.

$4995

Buy Report

Published: December 15, 2019 Report Code: GDMECC4563DB-ST

Report Overview
Table of Contents
Table
Figures

“What is covered in the report about the “United States Diagnostic and Measurement Devices Market”?
GlobalData’s “United States Diagnostic and Measurement Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Diagnostic and Measurement Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Capnographs, Peak Flow Meters, Pulse Oximeter Systems, Sleep Apnea Diagnostic Systems and Spirometers.

The United States Diagnostic and Measurement Devices Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Diagnostic and Measurement Devices market.
• Global corporate-level profiles of key companies operating within the United States Diagnostic and Measurement Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

United States Diagnostic and Measurement Devices is segmented as follows:
• Capnographs
• Peak Flow Meters
• Pulse Oximeter Systems
• Sleep Apnea Diagnostic Systems
• Spirometers

Key Reasons to Purchase
The United States Diagnostic and Measurement Devices Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Diagnostic and Measurement Devices Market Outlook to 2025” report
• Masimo Corp
• Medtronic plc
• Nihon Kohden Corp

The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 15,000+ primary interviews, conducted annually to ensure data and report quality
• 3,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 66.956+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 825+ companies’ revenue splits and market shares
• 2,000+ quarterly and annual medical equipment company financials
• 1,100+ medical equipment company SWOTs
• 27,500+ pipeline product profiles
• 55,100+ marketed product profiles
• 46,100+ clinical trials
• 52,400+ trial investigators
• 7,900+ reports on companies with products in development
• 41,700+ deals in the medical equipment industry
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx

Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Diagnostic and Measurement Devices Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Diagnostic and Measurement Devices Market, United States 11

3.1 Diagnostic and Measurement Devices Market, United States, Revenue ($m), 2015-2025 11

3.1.1 Capnographs Market, United States, Revenue ($m), by Segment, 2015-2025 14

3.1.2 Pulse Oximeter Systems Market, United States, Revenue ($m), by Segment, 2015-2025 16

3.1.3 Sleep Apnea Diagnostic Systems Market, United States, Revenue ($m), by Segment, 2015-2025 19

3.1.4 Spirometers Market, United States, Revenue ($m), by Segment, 2015-2025 21

3.2 Diagnostic and Measurement Devices Market, United States, Volume (Units), 2015-2025 23

3.2.1 Capnographs Market, United States, Volume (Units), by Segment, 2015-2025 26

3.2.2 Pulse Oximeter Systems Market, United States, Volume (Units), by Segment, 2015-2025 28

3.2.3 Sleep Apnea Diagnostic Systems Market, United States, Volume (Units), by Segment, 2015-2025 31

3.2.4 Spirometers Market, United States, Volume (Units), by Segment, 2015-2025 33

3.3 Diagnostic and Measurement Devices Market, United States, Average Price ($), 2015-2025 35

3.4 Diagnostic and Measurement Devices Market, United States, Distribution Share by Revenue ($m), 2018 37

3.5 Diagnostic and Measurement Devices Market, United States, Company Share by Revenue ($m), 2018 38

4 Overview of Key Companies in United States, Diagnostic and Measurement Devices Market 40

4.1 Masimo Corp 40

4.1.1 Company Overview 40

4.2 Medtronic Plc 40

4.2.1 Company Overview 40

4.3 Nihon Kohden Corp 40

4.3.1 Company Overview 40

4.4 Smiths Medical 41

4.4.1 Company Overview 41

4.5 Koninklijke Philips NV 41

4.5.1 Company Overview 41

4.6 Nonin Medical Inc 41

4.6.1 Company Overview 41

4.7 Becton Dickinson and Co 42

4.7.1 Company Overview 42

4.8 Compumedics Ltd 42

4.8.1 Company Overview 42

4.9 Natus Medical Incorporated 42

4.9.1 Company Overview 42

4.10 ResMed Inc 42

4.10.1 Company Overview 42

4.11 GIMA, SpA 43

4.11.1 Company Overview 43

4.12 GE Healthcare LLC 43

4.12.1 Company Overview 43

4.13 Cadwell Industries Inc 43

4.13.1 Company Overview 43

4.14 Medline Industries Inc 43

4.14.1 Company Overview 43

4.15 Rossmax International Ltd 44

4.15.1 Company Overview 44

4.16 TaiDoc Technology Corporation 44

4.16.1 Company Overview 44

4.17 Dragerwerk AG & Co KGaA 44

4.17.1 Company Overview 44

4.18 Innovo Medical Ltd 44

4.18.1 Company Overview 44

4.19 Vyaire Medical Inc 45

4.19.1 Company Overview 45

4.20 Philips Respironics Inc 45

4.20.1 Company Overview 45

5 Diagnostic and Measurement Devices Market Pipeline Products 46

6 Financial Deals Landscape 47

6.1 Acquisition 47

6.1.1 Edwards Lifesciences Acquires CAS Medical Systems 47

6.2 Debt Offerings 49

6.2.1 ResMed Raises USD250 Million in Private Placement of

3.24% Notes Due 2026 49

6.2.2 ResMed Raises USD250 Million in Private Placement of

3.45% Notes Due 2029 50

6.2.3 AMETEK Raises USD275 Million in Private Placement of

4.18% Senior Notes Due 2025 51

6.2.4 AMETEK Raises USD150 Million in Private Placement of

4.32% Senior Notes Due 2027 52

6.2.5 AMETEK Raises USD85 Million in Private Placement of

1.71% Senior Notes Due 2027 53

6.2.6 AMETEK to Raise USD100 Million in Private Placement of

4.32% Senior Notes Due 2027 54

6.3 Equity Offerings 55

6.3.1 Soleno Therapeutics Raises USD15.4 Million in Public Offering of Shares 55

6.4 Partnerships 57

6.4.1 Radiometer Medical and Perimed Enter into Distribution Agreement 57

6.5 Private Equity 58

6.5.1 Blackstone Group and Cinven May Bid for Smiths Medical 58

6.6 Venture Financing 60

6.6.1 Makani Science Raises USD0.55 Million in Venture Financing 60

6.6.2 Pulmonx Raises USD65 Million in Venture Financing 61

6.6.3 ALung Technologies Raises USD5 Million in Venture Financing 63

7 Recent Developments 64

7.1 Corporate Communications 64

7.1.1 Sep 25, 2019: Palo Alto Health Sciences appoints Joseph Perekupka as Chief Commercial Officer 64

7.1.2 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 64

7.1.3 Jun 17, 2019: AMETEK announces appointment of Tod E. Carpenter to Board of Directors 65

7.1.4 May 16, 2019: ResMed elects Jan De Witte to its Board of Directors 65

7.1.5 May 09, 2019: Pulmonx announces hiring of chief financial officer 65

7.1.6 Apr 29, 2019: Soleno Therapeutics names Gwen A. Melincoff to Board of Directors 66

7.1.7 Mar 08, 2019: Palo Alto Health Sciences obtains DMEPOS accreditation by HQAA 66

7.1.8 Feb 21, 2019: Nihon Kohden appoints new CEO of North American operations 67

7.1.9 Feb 13, 2019: Natus Medical announces continued board refreshment with two new independent directors 67

7.1.10 Feb 13, 2019: Thomas J. Matway elected vice president and general manager, specialty metal products division 68

7.1.11 Jan 15, 2019: Natus announces organizational enhancements, key leadership appointments 69

7.1.12 Jan 07, 2019: Julie A. Shimer Ph.D. joins Masimo’s board of directors 70

7.1.13 Dec 10, 2018: Medtronic named one of America's Best Corporate Citizens in 2018 by Forbes Magazine 70

7.1.14 Dec 10, 2018: Edwards Lifesciences will hire 370 employees for new facility 71

7.1.15 Nov 28, 2018: Palo Alto Health Sciences names Christopher S. Lento, MBA as chief commercial officer 71

7.1.16 Nov 20, 2018: ResMed names Harjit Gill to its Board of Directors 72

7.2 Financial Announcements 72

7.2.1 Oct 30, 2019: Masimo reports third quarter 2019 financial results 72

7.2.2 Oct 24, 2019: Natus Medical announces third quarter 2019 financial results 74

7.2.3 Oct 24, 2019: ResMed announces results for the first quarter of fiscal year 2020 76

7.2.4 Oct 23, 2019: Edwards Lifesciences reports third quarter results 77

7.2.5 Aug 07, 2019: Soleno Therapeutics provides corporate update and reports second quarter 2019 financial results 79

7.2.6 Jul 31, 2019: Masimo reports second quarter 2019 financial results 80

7.2.7 Jul 30, 2019: AMETEK announces second quarter results and raises 2019 guidance 81

7.2.8 Jul 25, 2019: ResMed announces results for the fourth quarter of fiscal year 2019 81

7.2.9 Jul 25, 2019: Natus Medical announces second quarter 2019 financial results 82

7.2.10 Jul 23, 2019: Edwards Lifesciences reports second quarter results for the year 2019 84

7.2.11 Jun 26, 2019: BioMarin announces acceptance of late breaking abstract at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia from July 6-10, 2019 85

7.2.12 Jun 12, 2019: Trial shows cardiovascular safety with Novo Nordisk’s diabetes drug 87

7.2.13 May 13, 2019: Soleno Therapeutics provides corporate update and reports first quarter 2019 financial results 88

7.2.14 May 06, 2019: Masimo reports first quarter 2019 financial results 89

7.2.15 May 06, 2019: Update to Natus Medical first quarter 2019 financial results 90

7.2.16 May 02, 2019: ResMed announces results for the third quarter of fiscal year 2019 90

7.2.17 Apr 25, 2019: Natus Medical announces first quarter 2019 financial results 91

7.2.18 Apr 23, 2019: Edwards Lifesciences announces first quarter results 92

7.2.19 Mar 18, 2019: Soleno Therapeutics provides corporate update and reports fourth quarter and full-year 2018 financial results 93

7.2.20 Feb 26, 2019: Masimo announces fourth quarter and full year 2018 financial results 95

7.2.21 Feb 26, 2019: Masimo reports fourth quarter and full year 2018 financial results 97

7.2.22 Feb 13, 2019: Natus Medical announces fourth quarter and full year 2018 financial results 99

7.2.23 Jan 31, 2019: Edwards Lifesciences reports financial results for the quarter ended December 31, 2018 100

7.2.24 Jan 24, 2019: ResMed announces results for the second quarter of fiscal year 2019 101

7.2.25 Jan 09, 2019: Masimo Announces Select Preliminary Full-Year 2018 Financial Results and 2019 Outlook 102

7.2.26 Jan 03, 2019: CASMED reports preliminary net sales for the 2018 fourth quarter and full year 103

7.2.27 Dec 05, 2018: Edwards Lifesciences outlines growth strategy at annual investor conference 2018 103

7.2.28 Nov 15, 2018: Soleno Therapeutics provides corporate update and reports third quarter 2018 financial results 105

7.3 Government and Public Interest 106

7.3.1 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare 106

7.4 Legal And Regulatory 107

7.4.1 Jan 22, 2019: Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences 107

7.4.2 Jan 15, 2019: Boston Scientific, Edwards Lifesciences agree to global litigation settlement 107

7.5 Other Significant Developments 107

7.5.1 Oct 10, 2019: CINDE announces Edwards Lifesciences invests $100 million to expand its operations in Costa Rica 107

7.5.2 Aug 22, 2019: ResMed chooses OneTrust to implement a global privacy program 108

7.5.3 Aug 01, 2019: Access Scientific unveils partnership with smiths medical to sell access' Powerwand product lines and completion of a $20m capital raise 109

7.5.4 Jul 10, 2019: Medtronic announces the early results of its cash tender offers for up to $5.525 billion of certain outstanding debt securities 109

7.5.5 Mar 22, 2019: Smiths announces its plans for the separation of Smiths Medical 110

7.6 Product News 111

7.6.1 Oct 15, 2019: Onxeo to present final results of DRIIV-1 phase 1 study of AsiDNA in advanced solid tumors at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 111

7.6.2 Feb 01, 2019: Smiths Medical issues a voluntary nationwide recall of sterile water and saline for inhalation USP products 111

7.7 Research And Development 112

7.7.1 Oct 15, 2019: Onxeo to present final results of DRIIV-1 phase 1 study of AsiDNA in advanced solid tumors at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 112

7.8 Strategy And Business Planning 113

7.8.1 Nov 15, 2018: Smiths Group to spin off medical devices unit 113

8 Appendix 114

8.1 Research Methodology 115

8.1.1 Coverage 115

8.1.2 Secondary Research 115

8.1.3 Primary Research 116

8.1.4 Market Modeling and Forecasting 117

8.1.5 Company Share Analysis 118

8.1.6 Distribution Share Analysis 119

8.1.7 Benchmarking 119

8.2 GlobalData Consulting 120

8.3 Contact Us 120

8.4 Disclaimer 120

Table

1.1 List of Tables

Table 1: Diagnostic and Measurement Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 12

Table 2: Diagnostic and Measurement Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 13

Table 3: Capnographs Market, United States, Revenue ($m), USD Constant, 2015-2020 15

Table 4: Capnographs Market, United States, Revenue ($m), USD Constant, 2021-2025 15

Table 5: Pulse Oximeter Systems Market, United States, Revenue ($m), USD Constant, 2015-2020 17

Table 6: Pulse Oximeter Systems Market, United States, Revenue ($m), USD Constant, 2021-2025 18

Table 7: Sleep Apnea Diagnostic Systems Market, United States, Revenue ($m), USD Constant, 2015-2020 20

Table 8: Sleep Apnea Diagnostic Systems Market, United States, Revenue ($m), USD Constant, 2021-2025 20

Table 9: Spirometers Market, United States, Revenue ($m), USD Constant, 2015-2020 22

Table 10: Spirometers Market, United States, Revenue ($m), USD Constant, 2021-2025 22

Table 11: Diagnostic and Measurement Devices Market, United States, Volume (Units), 2015-2020 24

Table 12: Diagnostic and Measurement Devices Market, United States, Volume (Units), 2021-2025 25

Table 13: Capnographs Market, United States, Volume (Units), 2015-2020 27

Table 14: Capnographs Market, United States, Volume (Units), 2021-2025 27

Table 15: Pulse Oximeter Systems Market, United States, Volume (Units), 2015-2020 29

Table 16: Pulse Oximeter Systems Market, United States, Volume (Units), 2021-2025 30

Table 17: Sleep Apnea Diagnostic Systems Market, United States, Volume (Units), 2015-2020 32

Table 18: Sleep Apnea Diagnostic Systems Market, United States, Volume (Units), 2021-2025 32

Table 19: Spirometers Market, United States, Volume (Units), 2015-2020 34

Table 20: Spirometers Market, United States, Volume (Units), 2021-2025 34

Table 21: Diagnostic and Measurement Devices Market, United States, Average Price ($), 2015-2020 35

Table 22: Diagnostic and Measurement Devices Market, United States, Average Price ($), 2021-2025 36

Table 23: Diagnostic and Measurement Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2018 37

Table 24: Diagnostic and Measurement Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2018 39

Table 25: Diagnostic and Measurement Devices Market Pipeline Products 46

Table 26: Edwards Lifesciences Acquires CAS Medical Systems 47

Table 27: ResMed Raises USD250 Million in Private Placement of 3.24% Notes Due 2026 49

Table 28: ResMed Raises USD250 Million in Private Placement of 3.45% Notes Due 2029 50

Table 29: AMETEK Raises USD275 Million in Private Placement of 4.18% Senior Notes Due 2025 51

Table 30: AMETEK Raises USD150 Million in Private Placement of 4.32% Senior Notes Due 2027 52

Table 31: AMETEK Raises USD85 Million in Private Placement of 1.71% Senior Notes Due 2027 53

Table 32: AMETEK to Raise USD100 Million in Private Placement of 4.32% Senior Notes Due 2027 54

Table 33: Soleno Therapeutics Raises USD15.4 Million in Public Offering of Shares 55

Table 34: Radiometer Medical and Perimed Enter into Distribution Agreement 57

Table 35: Blackstone Group and Cinven May Bid for Smiths Medical 58

Table 36: Makani Science Raises USD0.55 Million in Venture Financing 60

Table 37: Pulmonx Raises USD65 Million in Venture Financing 61

Table 38: ALung Technologies Raises USD5 Million in Venture Financing 63

Table 39: Total Number of Primary Research Participants, Anesthesia and Respiratory Devices Market, by Country 117

Figures

1.2 List of Figures

Figure 1: Diagnostic and Measurement Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 11

Figure 2: Capnographs Market, United States, Revenue ($m), USD Constant, 2015-2025 14

Figure 3: Pulse Oximeter Systems Market, United States, Revenue ($m), USD Constant, 2015-2025 16

Figure 4: Sleep Apnea Diagnostic Systems Market, United States, Revenue ($m), USD Constant, 2015-2025 19

Figure 5: Spirometers Market, United States, Revenue ($m), USD Constant, 2015-2025 21

Figure 6: Diagnostic and Measurement Devices Market, United States, Volume (Units), 2015-2025 23

Figure 7: Capnographs Market, United States, Volume (Units), 2015-2025 26

Figure 8: Pulse Oximeter Systems Market, United States, Volume (Units), 2015-2025 28

Figure 9: Sleep Apnea Diagnostic Systems Market, United States, Volume (Units), 2015-2025 31

Figure 10: Spirometers Market, United States, Volume (Units), 2015-2025 33

Figure 11: Diagnostic and Measurement Devices Market, United States, Company Share (%) 2018 38

Frequently asked questions

United States Diagnostic and Measurement Devices Market Outlook to 2025 standard reports

Currency USD

Single User

$4,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Anesthesia and Respiratory Devices reports

Medical Devices

New

PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…

Medical Devices

New

PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…

Medical Devices

New

Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Diagnostic and Measurement Devices Market Outlook to 2025 in real time.

Access a live United States Diagnostic and Measurement Devices Market Outlook to 2025 dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

United States Diagnostic and Measurement Devices Market Outlook to 2025

Scope

Table of Contents

Table

Figures

Frequently asked questions

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports